“…The residue was purified by column chromatography on silica gel using hexane−AcOEt (7:3, v/v) as eluent to give pyrrolidine 3g (58.0 mg, 69%) as a colorless solid. Mp 128−130 °C; [α] D 18 = 28.25 (c 1.1, CHCl 3 ); IR ν max 3491, 1339, 1163 cm −1 ; 1 H NMR (CDCl 3 ; 400 MHz) δ 7.77 (2H, d, J = 8.3 Hz), 7.30 (2H, d, J = 8.3 Hz), 6.17 (1H, br s), 4.61 (1H, d, J = 3.3 Hz), 4.01 (1H, dd, J = 15.0, 1.6 Hz), 3.96 (1H, dd, J = 15.0, 1.6 Hz), 3.69 (1H, d, J = 6.2 Hz), 2.41 (3H, s), 1.98−1.86 (1H, m), 1.60 (1H, br s), 1.00 (3H, d, J = 6.9 Hz), 0.90 (3H, d, J = 6.8 Hz); 13 (Z)-3-(Bromomethylene)-1-tosylpiperidin-4-ol (3h). Reduction of ester 1h (111.3 mg, 0.30 mmol), followed by radical cyclization of the resulting aldehyde, was carried out according to the same procedure as described for 3a to give piperidine 3h (78.1 mg, 76%) as a colorless oil [eluent: hexane−AcOEt−CHCl 3 (9:2:9, v/v)]; IR ν max 3494, 1348, 1332, 1164 cm −1 ; 1 H NMR (CDCl 3 ; 400 MHz) δ 7.65 (2H, d, J = 8.3 Hz), 7.33 (2H, d, J = 8.3 Hz), 6.29 (1H, d, J = 1.8 Hz), 4.91 (1H, br s), 4.10 (1H, dd, J = 12.7, 1.8 Hz), 3.64 (1H, ddd, J = 12.2, 4.6, 2.3 Hz), 3.30 (1H, dd, J = 12.7, 1.8 Hz), 2.84 (1H, dt, J = 12.2, 3.1 Hz), 2.44 (3H, s), 1.94−1.78 (2H, m), 1.60 (1H, br s); 13 (Z)-4-(Bromomethylene)-1-tosylpiperidin-3-ol (3j).…”